Skip to Content

Join the 'Trilipix' group to help and get support from people like you.

Trilipix News

FDA Medwatch Alert: Trilipix (fenofibric acid): Drug Safety Communication - Label Change

Posted 9 Nov 2011 by Drugs.com

ISSUE: FDA notified healthcare professionals the cholesterol-lowering medicine Trilipix (fenofibric acid) may not lower a patient's risk of having a heart attack or stroke. FDA reviewed the data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid trial. The ACCORD Lipid trial found no significant difference in the risk of experiencing a major adverse cardiac event between ...

Ask a Question

Further Information

Related Condition Support Groups

High Cholesterol, Hypertriglyceridemia

Trilipix Patient Information at Drugs.com